The number of confirmed cases of E.coli food poisoning in south Wales valleys has risen to 31 people in 16 schools.

As food suppliers face examination by investigators, there are fears the infections might increase

According to a study published this week, rheumatoid arthritis sufferers who do not get adequate relief from TNF-inhibitors, like etanercept or infliximab, a new drug may provide significant clinical and functional benefits.

Made by Bristol-Myers Squibb, Orencia is the first in a new class of drugs for the condition. On Sept. 6, an advisory panel to the Food and Drug Administration unanimously agreed the benefits of Orencia outweigh the risks and recommended the drug receive marketing approval

U.S. pharmaceutical company Eli Lilly and Co. plans to work in conjunction with an Indian firm to develop a drug using benign viruses to kill the deadly E.coli bacteria in cattle, the Indian company confirmed Thursday.

India's Ganganen Biotechnologies developed the drug and signed an agreement last week with Elanco Animal Health, Lilly's animal feed division. Janakiraman Ramachandran, chairman of Gangagen Biotechnologies, says they plan to convert the drug into a cattle feed supplement

A new study shows breast milk in mothers who have breastfed infants for more than a year is richer in fat and energy when compared to milk from moms who have been breastfeeding for just a few months.

The study, spearheaded by Dr. Dror Mandel of Tel Aviv University in Israel, is the first to look at the nutritional value of breast milk after prolonged nursing

The British Health Protection Agency says the general population and hospitals must report every suspected case of an E.coli strain that caused an outbreak in Shropshire in 2003-2004, and has been linked to 10 deaths.

Data from E.coli blood poisoning, which has doubled in the last ten years to over 17,000 cases annually, shows antibiotic resistance increased from 2 percent to 6 percent of cases from 2001-2004, giving the government cause for concern